B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies.
B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies. Int Rev Immunol. 2013 Aug; 32(4):397-427.